Skip to main content
SpringerLink
Log in

Hepatic Metastasis

  • Chapter
  • First Online:
Surgical Treatment of Colorectal Cancer

  • 1258 Accesses

Abstract

Colorectal cancer is the third most common cancer in the world. About 30–50% of the patients with colorectal cancer would develop liver metastasis in the course of their illness. About one-third of the metastatic liver lesions (CRM) are considered to be resectable, and long-term cure is not infrequently observed. Advances in the surgical management of CRM have certainly improved the chance of resection in recent years. While the selection criteria for open resection is becoming well established in most centers globally, the introduction of laparoscopy to liver resection has shown to be safe and feasible in many recent reported series. The controversy around the optimal approach for synchronous CRM remains unresolved, but the inception of laparoscopic liver surgery has favored the approach with simultaneous resections, especially when left lateral sectionectomy or other minor liver resections are required. On the other hand, various approaches have been proposed to improve the resectability rate for bilobar CRM. A two-stage hepatectomy was associated with a 5-year overall survival rate of up to 30–40%. Alternatively, the recently popularized ALPPS procedure conferred a 2-year overall survival rate of over 50%. For unresectable bilobar CRM, liver transplantation has been proposed to be an effective treatment under stringent selection criteria that, in turn, offered a 5-year overall survival rate up to 60%. A randomized control trial to compare its efficacy with resection is currently underway, and the outcome of this study will be of significance to ascertain its role in the surgical management of CRM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update. J Hepato-Biliary-Pancreat Surg. 2008;15(6):570–80.

    Article  Google Scholar 

  2. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150(3):195–203.

    Article  CAS  PubMed  Google Scholar 

  3. Akgul O, Cetinkaya E, Ersoz S, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20(20):6113–22.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29(8):1083–90.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sasaki K, Margonis GA, Andreatos N, Wilson A, Weiss M, Wolfgang C, et al. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab. Br J Surg. 2017;104(7):926–35.

    Article  CAS  PubMed  Google Scholar 

  7. Jung SW, Kim DS, YD Y, Han JH, Suh SO. Risk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis. Ann Surg Treat Res. 2016;90(5):257–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review. J Gastrointest Surg. 2017;21(6):1076–85.

    Article  PubMed  Google Scholar 

  9. Pandanaboyana S, Bell R, White A, Pathak S, Hidalgo E, Lodge P, et al. Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis. ANZ J Surg. 2016. https://doi.org/10.1111/ans.13588.

  10. Hibi T, Cherqui D, Geller DA, Itano O, Kitagawa Y, Wakabayashi G. Expanding indications and regional diversity in laparoscopic liver resection unveiled by the International Survey on Technical Aspects of Laparoscopic Liver Resection (INSTALL) study. Surg Endosc. 2016;30(7):2975–83.

    Article  PubMed  Google Scholar 

  11. Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg. 2016;263(4):761–77.

    Article  PubMed  Google Scholar 

  12. Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22(10):711–20.

    Article  PubMed  Google Scholar 

  13. Fretland AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg. 2017. https://doi.org/10.1097/SLA.0000000000002353.

  14. Martinez-Cecilia D, Cipriani F, Vishal S, Ratti F, Tranchart H, Barkhatov L, et al. Laparoscopic versus open liver resection for colorectal metastases in elderly and octogenarian patients: a multicenter propensity score based analysis of short- and long-term outcomes. Ann Surg. 2017;265(6):1192–200.

    Article  PubMed  Google Scholar 

  15. Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261(4):619–29.

    PubMed  Google Scholar 

  16. Polignano FM, Quyn AJ, Sanjay P, Henderson NA, Tait IS. Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc. 2012;26(9):2571–8.

    Article  PubMed  Google Scholar 

  17. Lupinacci RM, Andraus W, De Paiva Haddad LB, Carneiro D’ Albuquerque LA, Herman P. Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases: a systematic review. Tech Coloproctol. 2014;18(2):129–35.

    Article  CAS  PubMed  Google Scholar 

  18. Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg. 2011;254(2):234–42.

    Article  PubMed  Google Scholar 

  19. Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46(10 Suppl):S22–31.

    PubMed  Google Scholar 

  20. Spelt L, Andersson B, Nilsson J, Andersson R. Prognostic models for outcome following liver resection for colorectal cancer metastases: a systematic review. Eur J Surg Oncol. 2012;38(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  21. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240(6):1052–61. discussion 61–4.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18. discussion 18–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77(7):1254–62.

    Article  CAS  PubMed  Google Scholar 

  24. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto T, et al. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepato-Biliary-Pancreat Surg. 2004;11(2):79–83.

    Article  Google Scholar 

  25. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125–35.

    Article  PubMed  Google Scholar 

  26. Roberts KJ, White A, Cockbain A, Hodson J, Hidalgo E, Toogood GJ, et al. Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg. 2014;101(7):856–66.

    Article  CAS  PubMed  Google Scholar 

  27. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24(31):4983–90.

    Article  CAS  PubMed  Google Scholar 

  28. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243(1):1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Surgeon. 2015;13(2):83–90.

    Article  PubMed  Google Scholar 

  30. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15.

    Article  CAS  PubMed  Google Scholar 

  31. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg. 2003;90(8):963–9.

    Article  CAS  PubMed  Google Scholar 

  32. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery. 2008;143(2):259–70.

    Article  PubMed  Google Scholar 

  33. Feng Q, Wei Y, Zhu D, Ye L, Lin Q, Li W, et al. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable – a meta-analysis. PLoS One. 2014;9(8):e104348.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Yin Z, Liu C, Chen Y, Bai Y, Shang C, Yin R, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? Hepatology. 2013;57(6):2346–57.

    Article  PubMed  Google Scholar 

  35. She WH, Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, et al. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg. 2015;85(11):829–33.

    Article  PubMed  Google Scholar 

  36. Karoui M, Vigano L, Goyer P, Ferrero A, Luciani A, Aglietta M, et al. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg. 2010;97(9):1354–62.

    Article  CAS  PubMed  Google Scholar 

  37. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford). 2013;15(7):483–91.

    Article  Google Scholar 

  38. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248(6):994–1005.

    Article  PubMed  Google Scholar 

  39. Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98(10):1463–75.

    Article  CAS  PubMed  Google Scholar 

  40. Chan AC, Poon RT, Chan C, Lo CM. Safety of ALPPS procedure by the anterior approach for hepatocellular carcinoma. Ann Surg. 2016;263(2):e14–6.

    Article  PubMed  Google Scholar 

  41. de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255(3):415–7.

    Article  PubMed  Google Scholar 

  42. Lang SA, Loss M, Schlitt HJ. “In-situ split” (ISS) liver resection: new aspects of technique and indication. Zentralbl Chir. 2014;139(2):212–9.

    CAS  PubMed  Google Scholar 

  43. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405–14.

    Article  PubMed  Google Scholar 

  44. Chan AC, Poon RT, Lo CM. Modified anterior approach for the ALPPS procedure: how we do it. World J Surg. 2015;39(11):2831–5.

    Article  PubMed  Google Scholar 

  45. Truant S, Scatton O, Dokmak S, Regimbeau JM, Lucidi V, Laurent A, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management. Eur J Surg Oncol. 2015;41(5):674–82.

    Article  CAS  PubMed  Google Scholar 

  46. Chan ACY, Chok K, Dai JWC, Lo CM. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: complete-ALPPS versus partial-ALPPS. Surgery. 2017;161(2):357–64.

    Article  PubMed  Google Scholar 

  47. Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, et al. Prediction of mortality after alpps stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg. 2015;262(5):780–5. discussion 5–6.

    Article  PubMed  Google Scholar 

  48. Alvarez FA, Ardiles V, de Santibanes M, Pekolj J, de Santibanes E. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261(4):723–32.

    Article  PubMed  Google Scholar 

  49. Bjornsson B, Sparrelid E, Rosok B, Pomianowska E, Hasselgren K, Gasslander T, et al. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases – intermediate oncological results. Eur J Surg Oncol. 2016;42(4):531–7.

    Article  CAS  PubMed  Google Scholar 

  50. Adam R, Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, et al. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016;103(11):1521–9.

    Article  CAS  PubMed  Google Scholar 

  51. Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257(5):800–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

    Albert Chan

Authors
  1. Albert Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Chan .

Editor information

Editors and Affiliations

  1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea (Republic of)

    Nam Kyu Kim

  2. Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan

    Kenichi Sugihara

  3. Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan

    Jin-Tung Liang

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chan, A. (2018). Hepatic Metastasis. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5143-2_33

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5142-5

  • Online ISBN: 978-981-10-5143-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation